Clinical Trial Update: Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis [NA]

View source ↗

Summary

A pilot study of etoposide-based therapy with hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Etoposide (Etoposide)
• Hematopoietic cell transplantation

Snippet

Sponsor: Asan Medical Center | Conditions: Hemophagocytic Lymphohistiocytosis | NA | Status: TERMINATED